✦ LIBER ✦

Exploring the role of enoxaparin in the management of high-risk patients with non–ST-elevation acute coronary syndromes: The SYNERGY trial

✍ Scribed by Kenneth W. Mahaffey; James J. Ferguson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Obesity in patients with non-ST-segment

✍ Kenneth W. Mahaffey; Simon T. Tonev; Sarah A. Spinler; Glenn N. Levine; Richard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Racial Differences Among High-Risk Patie

✍ Melvin R. Echols; Kenneth W. Mahaffey; Anindita Banerjee; Karen S. Pieper; Amand 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Enoxaparin vs. unfractionated heparin in

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Clinical Benefit of Enoxaparin in Patien

✍ Uwe Zeymer; Anselm Gitt; Claus Jünger; Oliver Koeth; Ralf Zahn; Harm Wienbergen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Enoxaparin versus tinzaparin in non–ST-s

✍ Christos Katsouras; Lampros K. Michalis; Nikos Papamichael; Kostas Adamides; Kat 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Avoidance of routine revascularization i

✍ William E Boden 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 188 KB